Evolved Dependence in Response to Cancer

Trends in Ecology & Evolution
Frédéric ThomasBeata Ujvari

Abstract

Evolved dependence is a process through which one species becomes 'dependent' on another following a long evolutionary history of interaction. This happens when adaptations selected in the first species for interacting lead to fitness costs when the second species is not encountered. Evolved dependence is frequent in host-parasite interactions, where hosts may achieve a higher fitness in the presence of the parasite than in its absence. Since oncogenic manifestations are (i) ubiquitous across multicellular life, (ii) involved in parasitic-like interactions with their hosts, and (iii) have effectively driven the selection of numerous adaptations, it is possible that multicellular organisms display evolved dependence in response to oncogenic processes. We provide a comprehensive overview of the topic, including the implications for cancer prevention and treatment.

References

Apr 14, 1983·Nature·S Tonegawa
Dec 30, 1993·The New England Journal of Medicine·S J WinawerJ F Panish
Dec 1, 1994·Parasite : Journal De La Société Française De Parasitologie·Y Michalakis, M E Hochberg
Dec 15, 2000·Immunology Today·A F Ochsenbein, R M Zinkernagel
Apr 3, 2003·Nature Reviews. Cancer·Ruth EtzioniLeland Hartwell
Apr 6, 1957·British Medical Journal·M BURNET
Feb 27, 2004·Nature·Judah Folkman, Raghu Kalluri
Dec 14, 2004·Gut·R W SummersJ V Weinstock
Apr 15, 2005·Molecular Immunology·YuFeng PengKeith B Elkon
Nov 23, 2005·Oncology·Peter Carmeliet
Dec 20, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Roy M BremnesRafael Sirera
Feb 25, 2006·Nature Reviews. Cancer·Pier-Luigi LolliniGuido Forni
Jul 6, 2006·Advanced Drug Delivery Reviews·H Peter Vollmers, Stephanie Brändlein
Nov 17, 2006·Nature Reviews. Cancer·Lauren M F MerloCarlo C Maley
Jun 15, 2007·International Journal of Epidemiology·Arnold Rice Rich
Sep 11, 2007·Journal of Autoimmunity·Hans U Lutz
Sep 25, 2007·Journal of Autoimmunity·Stratis AvrameasPeggy Lymberi
Dec 7, 2007·Molecular Cancer·H Peter Vollmers, Stephanie Brändlein
Jan 3, 2008·Cancer Cell·Yves HüsemannChristoph A Klein
Jun 14, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DemicheliI D Gukas
Jul 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Menna E JonesDavid Pemberton
Sep 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·André A Fernandez, Molly R Morris
Dec 9, 2008·Trends in Immunology·Hans U LutzSrini Kaveri
Feb 3, 2009·Trends in Parasitology·Simon Fellous, Lucie Salvaudon
May 16, 2009·New Biotechnology·H Peter Vollmers, Stephanie Brändlein
May 29, 2009·The New England Journal of Medicine·Nicholas J ShaheenCharles J Lightdale
Nov 4, 2009·Clinical and Experimental Immunology·R Schwartz-AlbiezY Shoenfeld
Mar 23, 2010·Nature Reviews. Drug Discovery·Trevor T HanselAndrew J T George
Jun 1, 2010·Nature Medicine·Ritika JainiVincent K Tuohy
Jun 25, 2010·American Journal of Hematology·Jon E PetersonJudah Folkman
Oct 12, 2010·Clinical & Developmental Immunology·Joel F AldrichRonald C Kennedy
Mar 5, 2011·Cancer Prevention Research·Frank L MeyskensUNKNOWN C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee
May 26, 2011·Cancer Research·James DeGregori
Jun 10, 2011·Annals of Medicine·Vincent K Tuohy, Ritika Jaini

❮ Previous
Next ❯

Citations

Sep 5, 2018·Nature Communications·Erika H DawsonFrederic Mery
Nov 27, 2020·IScience·Justine BoutryFrédéric Thomas
Mar 31, 2021·ELife·Jean-Pascal CappFrédéric Thomas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.